Calcium Microcrystalline Hydroxyapatite (MCHA) is a calcium compound, containing minerals in their natural ratios, as well as residues of matrix, proteins, and glycosaminoglycans. MCHA supports bone mineral composition and can potentially reduce the risk of degenerative joint issues.‡
MCHA is raw bone prepared by a special low temperature process to preserve the protein content. The calcium thus provided is in an extremely bioavailable form. In addition, M.C.H.C with K1 and K2 may contain trace amounts of other beneficial minerals (such as phosphorus) that are naturally-occurring.‡
M.C.H.C with K1 and K2 has added boron. The body requires boron for healthy metabolism and is utilized in bone building. Some studies have shown that boron has mineral-conserving and hormone supporting actions that are helpful in women with low magnesium intake.‡
Vitamin D3 is added to support bone health since studies show that vitamin D mobilizes calcium and phosphorus, promotes intestinal absorption of calcium and phosphates, and increases kidney absorption of calcium of phosphorus allowing for higher blood levels of those minerals for use in bone building.‡
In addition, M.C.H.C with K1 and K2 supplies vitamin K. Several forms of vitamin K are used around the world as medicine such as vitamin K1 (phytonadione) and vitamin K2 (menaquinone). M.C.H.C with K1 and K2 provides both vitamin K1 and K2 which work with vitamin D to promote and support calcium utilization, which helps support bone formation.‡
Warning: If you are pregnant or lactating woman, have any health conditions, or are taking any medication, make sure to consult your healthcare provider prior to use.
‡ These statements have not been evaluated by the Food and Drug Administration.
These products are not intended to diagnose, treat, cure or prevent any disease.
Ingredients
Dosage
One capsule four times daily.
Count
120 Capsules
Science
O’Keefe JH, Bergman N, Carrera-Bastos P, Fontes-Villalba M, DiNicolantonio JJ, Cordain L. Nutritional strategies for skeletal and cardiovascular health: hard bones, soft arteries, rather than vice versa. Open Heart. 2016 Mar 22;3(1):e000325. doi: 10.1136/openhrt-2015-000325. PMID: 27042317; PMCID: PMC4809188.
Noor Z. Nanohydroxyapatite application to osteoporosis management. J Osteoporos. 2013;2013:679025. doi: 10.1155/2013/679025. Epub 2013 Oct 28. PMID: 24288653; PMCID: PMC3830883.
Bristow SM, Gamble GD, Stewart A, Horne L, House ME, Aati O, Mihov B, Horne AM, Reid IR. Acute and 3-month effects of microcrystalline hydroxyapatite, calcium citrate and calcium carbonate on serum calcium and markers of bone turnover: a randomised controlled trial in postmenopausal women. Br J Nutr. 2014 Nov 28;112(10):1611-20. doi: 10.1017/S0007114514002785. Epub 2014 Oct 2. PMID: 25274192.
Vannucci L, Fossi C, Quattrini S, Guasti L, Pampaloni B, Gronchi G, Giusti F, Romagnoli C, Cianferotti L, Marcucci G, Brandi ML. Calcium Intake in Bone Health: A Focus on Calcium-Rich Mineral Waters. Nutrients. 2018 Dec 5;10(12):1930. doi: 10.3390/nu10121930. PMID: 30563174; PMCID: PMC6316542.
Nordin BE. Calcium and osteoporosis. Nutrition. 1997 Jul-Aug;13(7-8):664-86. doi: 10.1016/s0899-9007(97)83011-0. PMID: 9263260.
van Ballegooijen AJ, Pilz S, Tomaschitz A, Grübler MR, Verheyen N. The Synergistic Interplay between Vitamins D and K for Bone and Cardiovascular Health: A Narrative Review. Int J Endocrinol. 2017;2017:7454376. doi: 10.1155/2017/7454376. Epub 2017 Sep 12. PMID: 29138634; PMCID: PMC5613455.
Lanham-New SA. “Importance of calcium, vitamin D and vitamin K for osteoporosis prevention and treatment.” Proc Nutr Soc. 2008;67:163-176.
Features :
Hygienic Product : Not Specified
Allergy : Not Specified
M.C.H.C. with K1 and K2 - 834K
Description
Calcium Microcrystalline Hydroxyapatite (MCHA) is a calcium compound, containing minerals in their natural ratios, as well as residues of matrix, proteins, and glycosaminoglycans. MCHA supports bone mineral composition and can potentially reduce the risk of degenerative joint issues.‡
MCHA is raw bone prepared by a special low temperature process to preserve the protein content. The calcium thus provided is in an extremely bioavailable form. In addition, M.C.H.C with K1 and K2 may contain trace amounts of other beneficial minerals (such as phosphorus) that are naturally-occurring.‡
M.C.H.C with K1 and K2 has added boron. The body requires boron for healthy metabolism and is utilized in bone building. Some studies have shown that boron has mineral-conserving and hormone supporting actions that are helpful in women with low magnesium intake.‡
Vitamin D3 is added to support bone health since studies show that vitamin D mobilizes calcium and phosphorus, promotes intestinal absorption of calcium and phosphates, and increases kidney absorption of calcium of phosphorus allowing for higher blood levels of those minerals for use in bone building.‡
In addition, M.C.H.C with K1 and K2 supplies vitamin K. Several forms of vitamin K are used around the world as medicine such as vitamin K1 (phytonadione) and vitamin K2 (menaquinone). M.C.H.C with K1 and K2 provides both vitamin K1 and K2 which work with vitamin D to promote and support calcium utilization, which helps support bone formation.‡
Warning: If you are pregnant or lactating woman, have any health conditions, or are taking any medication, make sure to consult your healthcare provider prior to use.
‡ These statements have not been evaluated by the Food and Drug Administration.
These products are not intended to diagnose, treat, cure or prevent any disease.
Ingredients
Dosage
One capsule four times daily.
Count
120 Capsules
Science
O’Keefe JH, Bergman N, Carrera-Bastos P, Fontes-Villalba M, DiNicolantonio JJ, Cordain L. Nutritional strategies for skeletal and cardiovascular health: hard bones, soft arteries, rather than vice versa. Open Heart. 2016 Mar 22;3(1):e000325. doi: 10.1136/openhrt-2015-000325. PMID: 27042317; PMCID: PMC4809188.
Noor Z. Nanohydroxyapatite application to osteoporosis management. J Osteoporos. 2013;2013:679025. doi: 10.1155/2013/679025. Epub 2013 Oct 28. PMID: 24288653; PMCID: PMC3830883.
Bristow SM, Gamble GD, Stewart A, Horne L, House ME, Aati O, Mihov B, Horne AM, Reid IR. Acute and 3-month effects of microcrystalline hydroxyapatite, calcium citrate and calcium carbonate on serum calcium and markers of bone turnover: a randomised controlled trial in postmenopausal women. Br J Nutr. 2014 Nov 28;112(10):1611-20. doi: 10.1017/S0007114514002785. Epub 2014 Oct 2. PMID: 25274192.
Vannucci L, Fossi C, Quattrini S, Guasti L, Pampaloni B, Gronchi G, Giusti F, Romagnoli C, Cianferotti L, Marcucci G, Brandi ML. Calcium Intake in Bone Health: A Focus on Calcium-Rich Mineral Waters. Nutrients. 2018 Dec 5;10(12):1930. doi: 10.3390/nu10121930. PMID: 30563174; PMCID: PMC6316542.
Nordin BE. Calcium and osteoporosis. Nutrition. 1997 Jul-Aug;13(7-8):664-86. doi: 10.1016/s0899-9007(97)83011-0. PMID: 9263260.
van Ballegooijen AJ, Pilz S, Tomaschitz A, Grübler MR, Verheyen N. The Synergistic Interplay between Vitamins D and K for Bone and Cardiovascular Health: A Narrative Review. Int J Endocrinol. 2017;2017:7454376. doi: 10.1155/2017/7454376. Epub 2017 Sep 12. PMID: 29138634; PMCID: PMC5613455.
Lanham-New SA. “Importance of calcium, vitamin D and vitamin K for osteoporosis prevention and treatment.” Proc Nutr Soc. 2008;67:163-176.
